Based on the provided information, it appears that the CAS number is not available, which makes it challenging to verify the chemical properties and characteristics. However, I will proceed with the description based on the chemical name provided.

Gal[2346Ac]β(1-3)GalN3[46Bzd]-β-MP is a specialized glycosylated compound that holds significant potential in biochemistry and pharmaceutical research. This compound is recognized for its unique structural features, which can enhance its interaction with biological systems, making it a valuable tool in the development of targeted therapies and drug delivery systems. Researchers have explored its applications in glycoengineering and the synthesis of glycoproteins, where its specific glycosylation patterns can influence biological activity and stability.

In addition to its applications in drug development, Gal[2346Ac]β(1-3)GalN3[46Bzd]-β-MP can be utilized in the study of cell signaling pathways and immune responses, providing insights into disease mechanisms and potential therapeutic targets. Its unique properties may also offer advantages over similar compounds, such as improved specificity and reduced side effects in therapeutic applications. This compound is ideal for researchers looking to innovate in the fields of glycobiology and medicinal chemistry.